MedTrace Logo

Prospective Analysis of In Vivo Laparoscopic Microwave Ablation Thermodynamics

NCT05471596 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2024-03-04

No results posted yet for this study

Summary

To prospectively collect and evaluate pre-operative, intra-operative, and post-operative variables for all patients undergoing surgical microwave ablation. All patients who have a surgical microwave ablation with the Neuwave system will be added to the database after their treatment and procedures have been completed.

Conditions

Interventions

DEVICE

NeuWave Microwave Ablation System

The NEUWAVE System supports target ablation or linear coagulation in surgical liver resection procedures. The System offers a versatile probe portfolio, multi-probe synchrony and CO2 cooling to help control the shape, size and burn pattern of your ablations.

Sponsors & Collaborators

  • Johnson & Johnson

    collaborator INDUSTRY

  • Wake Forest University Health Sciences

    lead OTHER

Principal Investigators

  • David A Iannitti, MD · Physician

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-14
Primary Completion
2023-11-17
Completion
2023-11-17
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05471596 on ClinicalTrials.gov